Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Tumor bed boost in breast cancer: Brachytherapy versus electron beam.

Roy S, Devleena, Maji T, Chaudhuri P, Lahiri D, Biswas J.

Indian J Med Paediatr Oncol. 2013 Oct;34(4):257-63. doi: 10.4103/0971-5851.125238.

PMID:
24604954
[PubMed]
Free PMC Article
2.

Brachytherapy or electron beam boost in conservation therapy of carcinoma of the breast: a nonrandomized comparison.

Perez CA, Taylor ME, Halverson K, Garcia D, Kuske RR, Lockett MA.

Int J Radiat Oncol Biol Phys. 1996 Mar 15;34(5):995-1007.

PMID:
8600112
[PubMed - indexed for MEDLINE]
3.

Electron and high-dose-rate brachytherapy boost in the conservative treatment of stage I-II breast cancer first results of the randomized Budapest boost trial.

Polgár C, Fodor J, Orosz Z, Major T, Takácsi-Nagy Z, Mangel LC, Sulyok Z, Somogyi A, Kásler M, Németh G.

Strahlenther Onkol. 2002 Nov;178(11):615-23.

PMID:
12426672
[PubMed - indexed for MEDLINE]
4.

Factors determining outcome in patients treated with interstitial implantation as a radiation boost for breast conservation therapy.

Wazer DE, Kramer B, Schmid C, Ruthazer R, Ulin K, Schmidt-Ullrich R.

Int J Radiat Oncol Biol Phys. 1997 Sep 1;39(2):381-93.

PMID:
9308942
[PubMed - indexed for MEDLINE]
5.

Thermal boost combined with interstitial brachytherapy in breast conserving therapy - Assessment of early toxicity.

Chicheł A, Skowronek J, Kanikowski M.

Rep Pract Oncol Radiother. 2011 Apr 8;16(3):87-94. doi: 10.1016/j.rpor.2011.02.004. eCollection 2011.

PMID:
24376963
[PubMed]
Free PMC Article
6.

Clinical outcome after treatment with a brachytherapy boost versus external beam boost for anal carcinoma.

Oehler-Jänne C, Seifert B, Lütolf UM, Studer G, Glanzmann C, Ciernik IF.

Brachytherapy. 2007 Jul-Sep;6(3):218-26.

PMID:
17681244
[PubMed - indexed for MEDLINE]
7.

Preliminary results of a phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer.

Wazer DE, Berle L, Graham R, Chung M, Rothschild J, Graves T, Cady B, Ulin K, Ruthazer R, DiPetrillo TA.

Int J Radiat Oncol Biol Phys. 2002 Jul 15;53(4):889-97.

PMID:
12095554
[PubMed - indexed for MEDLINE]
8.

Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.

Akimoto T, Ito K, Saitoh J, Noda SE, Harashima K, Sakurai H, Nakayama Y, Yamamoto T, Suzuki K, Nakano T, Niibe H.

Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):463-71.

PMID:
16168838
[PubMed - indexed for MEDLINE]
9.

Perioperative high-dose-rate interstitial brachytherapy boost for patients with early breast cancer.

Sharma DN, Deo SV, Rath GK, Shukla NK, Thulkar S, Madan R, Julka PK.

Tumori. 2013 Sep-Oct;99(5):604-10. doi: 10.1700/1377.15310.

PMID:
24362865
[PubMed - indexed for MEDLINE]
10.

Interstitial high-dose-rate brachytherapy boost: the feasibility and cosmetic outcome of a fractionated outpatient delivery scheme.

Manning MA, Arthur DW, Schmidt-Ullrich RK, Arnfield MR, Amir C, Zwicker RD.

Int J Radiat Oncol Biol Phys. 2000 Dec 1;48(5):1301-6.

PMID:
11121626
[PubMed - indexed for MEDLINE]
11.

Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.

Lu JJ, Shakespeare TP, Tan LK, Goh BC, Cooper JS.

Head Neck. 2004 May;26(5):389-95.

PMID:
15122654
[PubMed - indexed for MEDLINE]
12.

Long-term outcome with interstitial brachytherapy boost in the treatment of women with early-stage breast cancer.

Neumanova R, Petera J, Frgala T, Dusek L, Jarkovsky J, Kuricka R.

Neoplasma. 2007;54(5):413-23.

PMID:
17688371
[PubMed - indexed for MEDLINE]
13.

Cosmesis, late sequelae and local control after breast-conserving therapy: influence of type of tumour bed boost and adjuvant chemotherapy.

Budrukkar AN, Sarin R, Shrivastava SK, Deshpande DD, Dinshaw KA.

Clin Oncol (R Coll Radiol). 2007 Oct;19(8):596-603. Epub 2007 Aug 13.

PMID:
17706403
[PubMed - indexed for MEDLINE]
14.

Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study.

Reitsamer R, Peintinger F, Kopp M, Menzel C, Kogelnik HD, Sedlmayer F.

Strahlenther Onkol. 2004 Jan;180(1):38-44.

PMID:
14704843
[PubMed - indexed for MEDLINE]
15.

Results of high dose rate afterloading brachytherapy boost to conventional external beam radiation therapy for initial and locally advanced prostate cancer.

Pellizzon AC, Nadalin W, Salvajoli JV, Fogaroli RC, Novaes PE, Maia MA, Ferrigno R.

Radiother Oncol. 2003 Feb;66(2):167-72.

PMID:
12648788
[PubMed - indexed for MEDLINE]
16.

High-dose-rate brachytherapy for early breast cancer: an ambulatory technique.

Hennequin C, Durdux C, Espié M, Balla-Mekias S, Housset M, Marty M, Chotin G, Maylin C.

Int J Radiat Oncol Biol Phys. 1999 Aug 1;45(1):85-90.

PMID:
10477010
[PubMed - indexed for MEDLINE]
17.

Neoadjuvant interstitial high-dose-rate (HDR) brachytherapy combined with systemic chemotherapy in patients with breast cancer.

Roddiger SJ, Kolotas C, Filipowicz I, Kurek R, Kuner RP, Martin T, Baltas D, Rogge B, Kontova M, Hoffmann G, Pollow B, Zamboglou N.

Strahlenther Onkol. 2006 Jan;182(1):22-9.

PMID:
16404517
[PubMed - indexed for MEDLINE]
18.

Early breast cancer with positive margins: excellent local control with an upfront brachytherapy boost.

Schroeder TM, Liem B, Sampath S, Thompson WR, Longhurst J, Royce M.

Breast Cancer Res Treat. 2012 Jul;134(2):719-25. doi: 10.1007/s10549-012-2087-4. Epub 2012 May 16.

PMID:
22588673
[PubMed - indexed for MEDLINE]
19.

PDR brachytherapy with flexible implants for interstitial boost after breast-conserving surgery and external beam radiation therapy.

Fritz P, Berns C, Anton HW, Hensley F, Assman J, Flentje M, von Fournier D, Wannenmacher M.

Radiother Oncol. 1997 Oct;45(1):23-32.

PMID:
9364628
[PubMed - indexed for MEDLINE]
20.

Interim report of image-guided conformal high-dose-rate brachytherapy for patients with unfavorable prostate cancer: the William Beaumont phase II dose-escalating trial.

Martinez AA, Kestin LL, Stromberg JS, Gonzalez JA, Wallace M, Gustafson GS, Edmundson GK, Spencer W, Vicini FA.

Int J Radiat Oncol Biol Phys. 2000 May 1;47(2):343-52.

PMID:
10802358
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk